Alliancebernstein L.P. Albireo Pharma, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $41,423 - $54,694	2,300 Added 10.04%	25,200 $544,000
Q1 2022 May 13, 2022	BUY	$23.94 - $33.74 $2,394 - $3,374	100 Added 0.44%	22,900 $683,000
Q2 2021 Jul 30, 2021	BUY	$28.9 - $36.87 $57,800 - $73,740	2,000 Added 9.62%	22,800 $802,000
Q4 2020 Feb 08, 2021	SELL	$31.56 - $42.16 $56,808 - $75,888	-1,800 Reduced 7.96%	20,800 $780,000
Q3 2020 Nov 12, 2020	BUY	$23.19 - $41.61 $166,968 - $299,592	7,200 Added 46.75%	22,600 $754,000

Q2 2020 Aug 13, 2020	BUY	$14.82 - $29.92 $60,762 - $122,672	4,100 Added 36.28%	15,400 $408,000
Q1 2020 May 14, 2020	BUY	$11.67 - $27.23 $131,871 - $307,699	11,300 New	11,300 $185,000
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $128,000 - $204,032	-6,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $196,288 - $242,304	6,400 New	6,400 $206,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.